Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Bimatoprost
Allergan Australia Pty Ltd
Medicine Registered
LUMIGAN ® Bimatoprost Eye Drops-CMI Version 3.0 Page 1 of 4 LUMIGAN ® EYE DROPS (BIMATOPROST 0.3 MG PER ML) CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about LUMIGAN ® eye drops. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you using LUMIGAN ® eye drops against the benefits they expect it will have for you. If you have any concerns about using this medicine, ask your doctor or pharmacist. KEEP THIS LEAFLET WITH THE MEDICINE. YOU MAY NEED TO READ IT AGAIN. WHAT LUMIGAN ® EYE DROPS ARE USED FOR LUMIGAN ® eye drops are used to lower raised pressure in the eye and to treat glaucoma. Glaucoma is a condition in which the pressure of fluid in the eye may be high. However, some people with glaucoma may have normal eye pressure. Glaucoma is usually caused by a build up of the fluid which flows through the eye. This build up occurs because the fluid drains out of your eye more slowly than it is being pumped in. Since new fluid continues to enter the eye, joining the fluid already there, the pressure continues to rise. This raised pressure may damage the back of the eye resulting in gradual loss of sight. Damage can progress so slowly that the person is not aware of this gradual loss of sight. Sometimes even normal eye pressure is associated with damage to the back of the eye. There are usually no symptoms of glaucoma. The only way of knowing that you have glaucoma is to have your eye pressure, optic nerve and visual field checked by an eye specialist or optometrist. If Read the complete document
LUMIGAN ® Eye Drops Product Information Version 2.0 LUMIGAN ® EYE DROPS NAME OF THE DRUG The active constituent of LUMIGAN Ò eye drops is bimatoprost. Chemical structure: HO HO OH CON H C 2 H 5 CHEMICAL NAME: (Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1- pentenyl]cyclopentyl]-N-ethyl-5-heptenamide MOLECULAR WEIGHT: 415.58 EMPIRICAL FORMULA: C 25 H 37 NO 4 CAS REGISTRY NO.: 155206-00-1 DESCRIPTION Bimatoprost (LUMIGAN Ò eye drops 0.3mg/mL) is a prostamide with potent ocular hypotensive activity. Bimatoprost is a white to off-white powder and is very soluble in ethyl alcohol and methyl alcohol and slightly soluble in water. LUMIGAN Ò is a clear, isotonic, colourless, sterile ophthalmic solution with an osmolality of approximately 290mOsmol/kg. LUMIGAN Ò 0.3mg/mL is a sterile ophthalmic solution. Each mL of LUMIGAN Ò solution contains: ACTIVE: bimatoprost 0.3 mg PRESERVATIVE: benzalkonium chloride 0.05 mg INACTIVES: sodium phosphate dibasic; citric acid monohydrate; sodium chloride; and water - purified. Hydrochloric acid and/or sodium hydroxide may be added to adjust pH. PHARMACOLOGY _Pharmacotherapeutic group: opthalmologicals; prostaglandin analogues; ATC code: S01EE03 _ _Mechanism of action _ Bimatoprost is a novel synthetic prostamide analogue with potent ocular hypotensive activity. It selectively mimics the effects of a newly discovered naturally occurring substance, prostamide. Prostamide is biosynthesised from anandamide by a pathway involving COX-2 but not COX-1, suggesting a new pathway that leads to the synthesis LUMIGAN ® Eye Drops Product Information Version 2.0 of endogenous lipid amides that lower intraocular pressure (IOP). Bimatoprost and prostamides differ from prostaglandi Read the complete document